Follow-Up Extension Study of a Double-Blind Phase 3 Clinical Study of Recombinant Human Arylsulfatase B in Patients with Mucopolysaccharidosis Vi

AuthID
 P-000-4KE
10
Author(s)
Harmatz, P
·
Giugliani, R
·
Schwartz, I
·
Guffon, N
·
Teles, E
·
Wraith, JE
·
Beck, M
·
Hopwood, J
·
Swiedler, S
Document Type
Abstract
Year published
2005
Published
in MOLECULAR GENETICS AND METABOLISM, ISSN: 1096-7192
Volume: 84, Issue: 3, Pages: 237-238 (2)
Conference
Annual Meeting of the Society-For-Inherited-Metabolic-Disorders (Simd 2005), Date: MAR 06-09, 2005, Location: Pacific Grove, CA, Sponsors: Genzyme Corp, Mead Johnson Nutr, NIDDK, NIH, Off Rare Dis, Dept Hlth & Human Serv, Ucyclyd Pharma, Actelion Pharmaceut US Inc, Abbott Labs, Ross Prod Div, SHS N Amer, Appl Biosyst, Appl Nutr Corp, BioMarin Pharmaceut Inc, Milupa N Amer, Vitaflo, Biochrom Inc, Cambrooke Foods, Hitachi High Technologies Amer Inc, Natl Urea Cycle Defects Fdn, Pickering Labs Inc, Rare Dis Therapeut Inc, Sigma Tau Pharmaceut, Transkarot Therapies Inc
Indexing
Wos®
Publication Identifiers
Wos: WOS:000227648400101
Source Identifiers
ISSN: 1096-7192
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service